BRETT K HAUMANN Insider Trading $TBPH Theravance Biopharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BRETT K HAUMANN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BRETT K HAUMANN. BRETT K HAUMANN is Chief Medical Officer in Theravance Biopharma, Inc. ($TBPH) and SVP Clin Dev & Chief Med Ofc in Theravance Biopharma, Inc. ($TBPH) and SVP, Clinical Development in Theravance Biopharma, Inc. ($TBPH) and VP-Clinical Develop. in Theravance Biopharma, Inc. ($TBPH) and Director in Aimmune Therapeutics, Inc. ($AIMT).
BRETT K HAUMANN in Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BRETT K HAUMANN: Chief Medical Officer, SVP Clin Dev & Chief Med Ofc, SVP, Clinical Development, VP-Clinical Develop.
Holdings: 307,810 shares
Current Value: $9,418,986
Latest Transaction: Aug 24 2020
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BRETT K HAUMANN in Theravance Biopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | Chief Medical Offic ... | Sell | S | 18.29 | 25,000 | 457,240 | 282,810 | 307.8 K to 282.8 K (-8.12 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | Chief Medical Offic ... | Payment of Exercise | F | 18.22 | 4,646 | 84,650 | 307,810 | 312.5 K to 307.8 K (-1.49 %) |
| May 22 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 26.67 | 4,212 | 112,334 | 312,456 | 316.7 K to 312.5 K (-1.33 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 25.90 | 33,608 | 870,447 | 316,668 | 350.3 K to 316.7 K (-9.59 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 54,000 | 0 | 350,276 | 296.3 K to 350.3 K (+18.23 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 65,000 | 0 | 296,276 | 231.3 K to 296.3 K (+28.10 %) |
| Aug 22 2019 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 21.51 | 2,710 | 58,292 | 233,968 | 236.7 K to 234 K (-1.15 %) |
| May 22 2019 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 19.84 | 2,705 | 53,667 | 236,678 | 239.4 K to 236.7 K (-1.13 %) |
| Feb 22 2019 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 27.00 | 7,778 | 210,006 | 239,383 | 247.2 K to 239.4 K (-3.15 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 47,250 | 0 | 247,161 | 199.9 K to 247.2 K (+23.64 %) |
| Feb 07 2019 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 65,000 | 0 | 199,911 | 134.9 K to 199.9 K (+48.18 %) |
| Nov 21 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 24.79 | 7,368 | 182,653 | 134,911 | 142.3 K to 134.9 K (-5.18 %) |
| Aug 22 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 26.95 | 6,683 | 180,107 | 142,279 | 149 K to 142.3 K (-4.49 %) |
| May 22 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 24.31 | 26,991 | 656,151 | 148,962 | 176 K to 149 K (-15.34 %) |
| May 16 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 33,750 | 0 | 175,953 | 142.2 K to 176 K (+23.73 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 29.09 | 8,293 | 241,243 | 142,203 | 150.5 K to 142.2 K (-5.51 %) |
| Nov 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 28.58 | 7,846 | 224,239 | 141,496 | 149.3 K to 141.5 K (-5.25 %) |
| Aug 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 27.40 | 7,064 | 193,554 | 149,342 | 156.4 K to 149.3 K (-4.52 %) |
| May 23 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 36.83 | 7,065 | 260,204 | 156,406 | 163.5 K to 156.4 K (-4.32 %) |
| Mar 08 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 30.80 | 424 | 13,059 | 163,471 | 163.9 K to 163.5 K (-0.26 %) |
| Mar 08 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 31.52 | 13,576 | 427,916 | 163,895 | 177.5 K to 163.9 K (-7.65 %) |
| Feb 22 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 33.78 | 14,434 | 487,581 | 177,471 | 191.9 K to 177.5 K (-7.52 %) |
| Feb 08 2017 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 9,000 | 0 | 191,905 | 182.9 K to 191.9 K (+4.92 %) |
| Nov 22 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 31.96 | 5,388 | 172,200 | 182,905 | 188.3 K to 182.9 K (-2.86 %) |
| Aug 25 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 27.99 | 4,491 | 125,703 | 188,293 | 192.8 K to 188.3 K (-2.33 %) |
| Aug 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 27.89 | 4,607 | 128,489 | 192,784 | 197.4 K to 192.8 K (-2.33 %) |
| Aug 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Sell | S | 27.97 | 9,509 | 265,967 | 197,391 | 206.9 K to 197.4 K (-4.60 %) |
| May 24 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Payment of Exercise | F | 20.55 | 4,608 | 94,694 | 206,900 | 211.5 K to 206.9 K (-2.18 %) |
| Mar 17 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP Clin Dev & Chie ... | Grant | A | 0.00 | 90,000 | 0 | 211,508 | 121.5 K to 211.5 K (+74.07 %) |
| Feb 23 2016 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Payment of Exercise | F | 15.65 | 18,425 | 288,351 | 121,508 | 139.9 K to 121.5 K (-13.17 %) |
| Nov 24 2015 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Payment of Exercise | F | 17.17 | 781 | 13,410 | 139,933 | 140.7 K to 139.9 K (-0.56 %) |
| Feb 09 2015 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | SVP, Clinical Devel ... | Grant | A | 0.00 | 135,000 | 0 | 140,714 | 5.7 K to 140.7 K (+2,362.62 %) |
| Jun 05 2014 | TBPH | Theravance Biophar ... | HAUMANN BRETT K | VP-Clinical Develop ... | Option Exercise | A | 23.51 | 59,375 | 1,395,906 | 59,375 |
Page: 1